Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-05
1997-05-06
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514261, 514262, 514885, 514894, 544264, 544265, A61K 3152
Patent
active
056271859
ABSTRACT:
Derivatives of Acyclovir are provided having patent antiviral inhibitory activity. Phosphotriester derviatives are preferred which have the structure: ##STR1## where R is alkyl, especially CH.sub.3 or (CH.sub.3).sub.3 C.
REFERENCES:
patent: 4294831 (1981-10-01), Schaffer
patent: 4355032 (1982-10-01), Verheyden et al.
patent: 5284837 (1994-02-01), Lindborg et al.
patent: 5494912 (1996-02-01), Halazy et al.
Hao et al., "2', 3'-Dideoxyuridine Triphosphate: A Potent Inhibitor of HIV Reverse Transcriptase," Proceedings of AACR, vol. 29, p. 348 (1988).
Hao et al., Molecular Pharmacology, vol. 37, pp. 157-163 (1989).
Rosenberg et al., Collection Czech Chem. Commun., vol. 52 pp. 2792-2800. (1987).
Matthes et al., Biochem and Biophysical Research Commun., vol. 148, No. 1, pp. 78-85, (1987).
Gosselin Gilles
Imbach Jean-Louis
LandOfFree
Acyclovir derivatives as antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyclovir derivatives as antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyclovir derivatives as antiviral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2132860